<DOC>
	<DOCNO>NCT02713113</DOCNO>
	<brief_summary>investigator aim compare efficacy safety sugammadex dose 1.5 , 2 , 4 mg/ kg reversal moderate rocuronium-induced neuromuscular blockade laparoscopic bariatric surgery .</brief_summary>
	<brief_title>Efficacy Low Dose Sugammadex Reversal NMB Laparoscopic Barbaric Surgery</brief_title>
	<detailed_description>Patients randomly assign use randomization-computer program three group accord dose sugammadex administrate ( accord IBW T2 TOF ) : Group I : patient give 1.5 mg / kg . Group II : patient give 2 mg / kg . Group III : patient give 4 mg / kg .</detailed_description>
	<criteria>morbidly obese patient sex ( BMI &gt; 40 kg.m2 ) schedule elective laparoscopic bariatric surgery ( gastric bypass sleeve surgery ) general anesthesia use rocuronium tracheal intubation maintenance NMB age 18 60 year classify ASA II III liver renal dysfunction , disable neuropsychiatric disorder , history stroke , brain trauma last 12 month hypersensitivity anesthetic , history myocardial infarction , congestive heart failure difficult tracheal intubation , know suspected disorder affect NMB .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>